The concept of a role for IgE in conferring immune protection against cancer dates back many decades, with early studies providing evidence for a role of allergic responses in restricting tumour xenograft growth in mice, negative correlations between atopy and cancer [98,99,100,101,102], and decreased prevalence of immediate hypersensitivity in patients with cancer [103]. This evidence concerns the gene IGHE and neoplasm.